Dec 31, 2025 08:42AM Jefferies: 'We see this as a positive for XERS'

Nov 6, 2025 07:01AM Xeris Pharmaceuticals Inc. (XERS) Misses Q3 EPS by 1c ; Offers Guidance

Aug 25, 2025 07:00AM Xeris receives Orange Book listing for Recorlev patent extending to 2040

Aug 19, 2025 04:38PM Xeris Pharmaceuticals (XERS) PT Raised to $9 at Leerink Partners

Aug 12, 2025 06:35AM H.C. Wainwright Assumes Xeris Pharmaceuticals (XERS) at Buy

Aug 7, 2025 07:03AM Xeris Pharmaceuticals Inc. (XERS) Tops Q2 EPS by 2c, provides guidance

Jun 5, 2025 04:43AM Xeris Pharmaceuticals (XERS) PT Raised to $7 at Leerink Partners

Jun 3, 2025 07:30AM Xeris Pharmaceuticals Inc. (XERS) Unveils Strategy for Long-Term Growth and Value Creation at 2025 Analyst & Investor Day

May 8, 2025 07:03AM Xeris Pharmaceuticals Inc. (XERS) Misses Q1 EPS by 1c, provides guidance

Mar 28, 2025 08:01AM Xeris Pharmaceuticals (XERS) Announces Board Changes

Mar 17, 2025 08:03AM Xeris Pharmaceuticals Inc. (XERS) Announces Approval of Supplemental New Drug Application (sNDA) of Gvoke VialDx

Mar 7, 2025 06:40AM Xeris Pharmaceuticals (XERS) PT Raised to $8 at H.C. Wainwright

Mar 6, 2025 05:00PM Xeris Pharmaceuticals Inc. (XERS) Files $250M Mixed Shelf

Mar 6, 2025 07:04AM Xeris Pharmaceuticals Inc. (XERS) Tops Q4 EPS by 3c, provides guidance

Feb 24, 2025 08:01AM Xeris Pharmaceuticals Inc. (XERS) Appoints Anh Nguyen as Chief Medical Officer

Jan 10, 2025 07:05AM Xeris Pharmaceuticals Inc. (XERS) Expects to Exceed Full-Year 2024 Financial Guidance

Nov 11, 2024 07:25AM Xeris Pharmaceuticals (XERS) PT Raised to $6.60 at H.C. Wainwright

Nov 11, 2024 12:41AM Piper Sandler Downgrades Xeris Pharmaceuticals (XERS) to Neutral

Nov 8, 2024 07:03AM Xeris Pharmaceuticals Inc. (XERS) Misses Q3 EPS by 2c, provides guidance

Oct 23, 2024 06:18AM Oppenheimer Reiterates Outperform Rating on Xeris Pharmaceuticals (XERS)

Aug 8, 2024 07:11AM Xeris Pharmaceuticals Inc. (XERS) Reports In-Line Q2 EPS ; Offers Guidance